Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
greater decrease » greater increase (Expand Search), greater disease (Expand Search), rate decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
greater decrease » greater increase (Expand Search), greater disease (Expand Search), rate decreased (Expand Search)
-
2181
-
2182
Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.
Published 2025Subjects: -
2183
Inequalities in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.
Published 2025Subjects: -
2184
Trends in full immunization coverage among two-year-olds in Sierra Leone, 2008-2019.
Published 2025Subjects: -
2185
-
2186
Receiver operating characteristic curve for anti-NIE antibodies for <i>S. stercoralis.</i>
Published 2025“…The seroprevalence did not significantly decrease following DA treatment. These results include all individuals sampled, irrespective of whether they took the medications. …”
-
2187
NIE ELISA results.
Published 2025“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”
-
2188
Kato Katz and PCR database 12 months collection.
Published 2025“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”
-
2189
Master database baseline, 4 weeks and 1 year.
Published 2025“…Twelve months post-MDA, hookworm prevalence decreased to 56.5% in DA- and 34.4% in IDA-treated villages, respectively (<i>p</i><0.001, both comparisons). …”
-
2190
-
2191
-
2192
-
2193
-
2194
Composition of the gut microbiota at the genus level following the administration of MP.
Published 2025Subjects: -
2195
-
2196
-
2197
-
2198
Activity of xylanase in mixed feed and liver (mg saccharide/g sample/h), n = 12/treatment.
Published 2024Subjects: -
2199
-
2200
Composition of the gut microbiota at the phylum level following the administration of MP.
Published 2025Subjects: